Immunologic roles of hyaluronan

Immunologic Research

Volumn 31, Issue 3, 2005, Pages 189-205

  Mummert, Mark E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adhesion Theory; Filler Theory; Hyaluronan; Langerhans cell; Signaling Theory

Indexed keywords

CYTOKINE; GLUCURONIC ACID; GLYCOSAMINOGLYCAN; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; N ACETYLGLUCOSAMINE; PEPTIDE DERIVATIVE; PEPTIDE PEP 1; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; CELL MATURATION; CELL MIGRATION; CELL STRUCTURE; CELL TRANSPORT; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; IMMUNITY; LANGERHANS CELL; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKIN; T LYMPHOCYTE; THEORY;

ANIMALS; ANTIGEN PRESENTATION; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; CYSTEAMINE; HUMANS; HYALURONIC ACID; LANGERHANS CELLS; PEPTIDES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 18244402390     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:31:3:189     Document Type: Review

References (104)

1. Streilein JW, Toews GT, Gilliam JN, Bergstresser PR: Tolerance or hypersensitivity to 2,4-dinitro-1-fluorobenzene: the role of Langerhans cell density within epidermis. J Invest Dermatol 1980;74:319-322.
2. Streilein JW, Bergstresser PR: Langerhans cell function dictates induction of contact hypersensitivity or unresponsiveness to DNFB in Syrian hamsters. J Invest Dermatol 1981;77:272-277.
3. Pehamberger H, Stingl LA, Pogantsch S, Steiner G, Wolff K, Stingl G: Epidermal cell-induced generation of cytotoxic T-lymphocyte responses against alloantigens or TNP-modified syngeneic cells: requirement for Ia-positive Langerhans cells. J Invest Dermatol 1983;81:208-211.
4. Hauser C, Yokoyama WM, Katz SI: Characterization of primary T helper cell activation and T helper cell lines stimulated by hapten-modified, cultured Langerhans cells. J Invest Dermatol 1989;93:649-655.
5. Kolde G: Effects of immunological responsiveness on Langerhans cell behavior in contact sensitization. Exp Dermatol 1994;3:269-275.
6. Antonopoulos C, Cumberbatch M, Dearman RJ, Daniel RJ, Kimber I, Groves RW: Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J Immunol 2001;166: 3672-3677.
7. Wang B, Amerio P, Sauder DN: Role of cytokines in epidermal Langerhans cell migration. J Leukoc Biol 1999;66:33-39.
8. Cumberbatch M, Dearman RJ, Griffiths CE, Kimber I: Langerhans cell migration. Clin Exp Dermatol 2000; 25:413-418.
9. Kimber I, Cumberbatch M, Dearman RJ, Bhushan M, Griffiths CE: Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br J Dermatol 2000;142:401-412.
10. Fraser JR, Laurent TC, Laurent UB: Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997;242:27-33.
11. Tamaki K, Yasaka N, Chang CH, et al: Identification and characterization of novel dermal Thy-1 antigen-bearing dendritic cells in murine skin. J Invest Dermatol 1996;106:571-575.
12. Termeer CC, Hennies J, Voith U, et al: Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000;165:1863-1870.
13. Galandrini R, Galluzzo E, Albi N, Grossi CE, Velardi A: Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. J Immunol 1994;153:21-31.
14. Dirks W, Schöne S, Uphoff C, Quentmeier H, Pradella S, Drexler HG: Expression and function of CD95 (FAS/APO-1) in leukemia-lymphoma tumour lines. Br J Haematol 1997;96:584-593.
15. Banchereau J, Briere F, Caux C, et al: Immunobiology of dendritic cells. Annu Rev Immunol 2000;18: 767-811.
16. Tamaki K, Fujiwara H, Katz SI: The role of epidermal cells in the induction and suppression of contact sensitivity. J Invest Dermatol 1981;76:275-278.
17. Sullivan S, Bergstresser PR, Tigelaar RE, Streilein JW: Induction and regulation of contact hypersensitivity by resident, bone-marrow derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells. J Immunol 1986;137:2460-2467.
18. Moll H, Fuchs H, Blank C, Rollinghoff M: Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur J Immunol 1993;23:1595-1601.
19. Moll H, Flohé S, Röllinghoff M: Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur J Immunol 1995;25:693-699.
20. Nonacs R, Humborg C, Tam JP, Steinman RM: Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes. J Exp Med 1992;176:519-529.
21. Inaba K, Inaba M, Naito M, Steinman RM: Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisma, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 1993;178:479-488.
22. Grabbe S, Bruvers S, Gallo RL, Knisely TL, Nazareno R, Granstein RD: Tumor antigen presentation by murine epidermal cells. J Immunol 1991;146:3656-3661.
23. Ludewig B, Odermatt B, Landmann S, Hengartner H, Zinkernagel RM: Dendritic cells induce autoimmune diabetes and maintain disease via De Novo formation of local lymphoid tissue. J Exp Med 1998;188:1493-1501.
24. Maurer D, Stingl G: Dendritic cells in the context of skin immunity: in Lotze MT, Thomson AW (eds): Dendritic Cells: Biology and Clinical Applications. San Diego, Academic, 1999, pp 111-122.
25. Cumberbatch M, Kimber I: Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 1995;84:31-35.
26. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM: Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med 1995;181:2237-2247.
27. Dieu M-C, Vanbervliet B, Vicari A, et al: Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sties. J Exp Med 1998;188:373-386.
28. Sozzani S, Allavena P, D'Amico G, et al: Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 1998;161:1083-1086.
29. Ogata M, Zhang Y, Wang Y, et al: Chemotactic response toward chemokines and its regulation by transforming growth factor-β1 of murine bone marrow hematopoietic progenitor cell-derived different subset of dendritic cells. Blood 1999;93:3225-3232.
30. Saeki H, Moore AM, Brown MJ, Hwang ST: Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 1999;162:2472-2475.
31. Liu YJ, Kanzler H, Soumelis V, Gilliet M: Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol 2001;2:585-589.
32. Giannoukakis N, Bonham CA, Qian S, et al: Prolongation of cardiac allograft survival using dendritic cells treated with NFκB decoy oligodeoxyribonucleotides. Mol Ther 2000;1:430-437.
33. Morelli AE, Larregina AT, Ganster RW, et al: Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway. J Virol 2000; 74:9617-9628.
34. Weigel PH, Hascall VC, Tammi M: Hyaluronan synthases. J Biol Chem 1997;272:13,997-14,000.
35. Mohamadzadeh M, DeGrendele H, Arizpe H, Estess P, Siegelman M: Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J Clin Invest 1998;101:97-108.
36. Estess P, Nandi A, Mohamadzadeh M, Siegelman MH: Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo. J Exp Med 1999;190:9-19.
37. Camenisch TD, Spicer AP, Brehm-Gibson T, et al: Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 2000;106:349-360.
38. Frost GI, Csoka TB, Wong T, Stern R: Purification, cloning, and expression of human plasma hyaluronidase. Biochem Biophys Res Commun 1997; 236:10-15.
39. Gmachl M, Sagan S, Ketter S, Kreil G: The human sperm protein PH-20 has hyaluronidase activity. FEBS Lett 1993;336:545-548.
40. Lepperdinger G, Strobl B, Kreil G: HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem 1998;273:22,466-22,470.
41. Csoka TB, Frost GI, Wong T, Stern R: Purification and microsequencing of hyaluronidase isozymes from human urine. FEBS Lett 1997;417:307-410.
42. Roden L, Campbell P, Fraser JR, Laurent TC, Pertoft H, Thompson JN: Enzymic pathways of hyaluronan catabolism. Ciba Found Symp 1989;143:60-76.
43. Natowicz MR, Short MP, Wang Y, et al: Clinical and biochemical manifestations of hyaluronidase deficiency. N Engl J Med 1996;335:1029-1033.
44. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-1313.
45. Miyake K, Underhill CB, Lesley J, Kincade PW: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990;172:69-75.
46. Hardingham TE: The role of link-protein in the structure of cartilage proteoglycan aggregates. Biochem J 1979;177:237-247.
47. Watanabe H, Cheung SC, Itano N, Kimata K, Yamada Y: Identification of hyaluronan-binding domains of aggrecan. J Biol Chem 1997;272:28,057-28,065.
48. LeBaron RG, Zimmermann DR, Ruoslahti E: Hyaluronate binding properties of versican. J Biol Chem 1992;267:10,003-10,010.
49. Delpech B, Halavent C: Characterization and purification from human brain of a hyaluronic acid-binding glycoprotein, hyaluronectin. J Neurochem 1981;36:855-859.
50. Rauch U, Karthikeyan L, Maurel P, Margolis RU, Margolis RK: Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain. J Biol Chem 1992;267:19,536-19,547.
51. Banerji S, Ni J, Wang SX, et al: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801.
52. Prevo R, Banerji S, Ferguson DJ, Clasper S, Jackson DG: Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 2001;276:19,420-19,430.
53. Entwistle J, Hall CL, Turley EA: HA receptors: regulators of signalling to the cytoskeleton. J Cell Biochem 1996;61:569-577.
54. Siegelman MH, DeGrendele HC, Estess P: Activation and interaction of CD44 and hyaluronan in immunological systems. J Leukoc Biol 1999;66:315-321.
55. Johnson P, Maiti A, Brown KL, Li R: A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response? Biochem Pharmacol 2000;59:455-465.
56. 2+-independent adhesion pathway in lymphocyte-endothelial cell interaction. Eur J Immunol 1993;23:439-446.
57. Fujii K, Tanaka Y, Hubscher S, Saito K, Ota T, Eto S: Cross-linking of CD44 on rheumatoid synovial cells up-regulates VCAM-1. J Immunol 1999;162:2391-2398.
58. Guo YJ, Ma J, Wong JH, et al: Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas. Cell Immunol 1993; 152:186-199.
59. Bourguignon LY, Lokeshwar VB, Chen X, Kerrick WG: Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/ CD44)-cytoskeleton interaction. J Immunol 1993;151: 6634-6644.
60. Khaldoyanidi S, Moll J, Karakhanova S, Herrlich P, Ponta H: Hyaluronate-enhanced hematopoiesis: two different receptors trigger the release of interleukin-1β and interleukin-6 from bone marrow macrophages. Blood 1999;94:940-949.
61. Horton MR, Burdick MD, Strieter RM, Bao C, Noble PW: Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-γ in mouse macrophages. J Immunol 1998;160:3023-3030.
62. Fitzgerald KA, O'Neill LA: Characterization of CD44 induction by IL-1 : a critical role for Egr-1. J Immunol 1999;162:4920-4927.
63. McKallip RJ, Do Y, Fisher MT, Robertson JL, Nagarkatti PS, Nagarkatti M: Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and super-antigens. Int Immunol 2002;14:1015-1026.
64. Takahashi K, Eto H, Tanabe KK: Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells. Int J Cancer 1999;80:387-395.
65. Yu Q, Stamenkovic I: Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 1998;13:35-48.
66. Knutson JR, Iida J, Fields GB, McCarthy JB: CD44/chondroitin sulfate proteoglycan and α2β1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol Biol Cell 1996;7:383-396.
67. Jalkanen S, Jalkanen M: Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 1992;116:817-825.
68. Sleeman JP, Kondo K, Moll J, Ponta H, Herrlich P: Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J Biol Chem 1997;272:31,837-31,844
69. Weber GF, Ashkar S, Glimcher MJ, Cantor H: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996;271:509-512.
70. Mummert ME, Mohamadzadeh M, Mummert DI, Mizumoto N, Takashima A: Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J Exp Med 2000;192:769-779.
71. Bárdos T, Kamath RV, Mikecz K, Giant TT: Anti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor-α-stimulated gene-6) in murine models of experimental arthritis. Am J Pathol 2001;159:1711-1721.
72. Gerdin B, Hallgren R: Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation. J Intern Med 1997;242:49-55.
73. Ogawa M, Hirano H, Tsubaki H, Kodama H, Tanaka T: The role of cytokines in cervical ripening: correlations between the concentrations of cytokines and hyaluronic acid in cervical mucus and the induction of hyaluronic acid production by inflammatory cytokines by human cervical fibroblasts. Am J Obstet Gynecol 1998; 179:105-110.
74. Tammi R, Ripellino JA, Margolis RU, Maibach HI, Tammi M: Hyaluronate accumulation in human epidermis treated with retinoic acid in skin organ culture. J Invest Dermatol 1989;92:326-332.
75. Agren UM, Tammi M, Tammi R: Hydrocortisone regulation of hyaluronan metabolism in human skin organ culture. J Cell Physiol 1995;164:240-248.
76. Pienimaki JP, Rilla K, Fulop C, et al: Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan. J Biol Chem 2001;276:20,428-20,435.
77. Hayen W, Goebeler M, Kumar S, Riessen R, Nehls V: Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture. J Cell Sci 1999;112(Pt 13):2241-2251.
78. Brecht M, Mayer U, Schlosser E, Prehm P: Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J 1986;239:445-450.
79. Evanko SP, Angello JC, Wight TN: Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999;19:1004-1013.
80. Hardwick C, Hoare K, Owens R, et al: Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 1992;117:1343-1350.
81. DeGrendele H, Estess P, Picker LJ, Siegelman MH: CD44 and its ligand hayluronate mediate rolling under physiologic flow: a novel lymphocyte- endothelial cell primary adhesion pathway. J Exp Med 1996;183: 1119-1130.
82. DeGrendele HC, Estess P, Siegelman MH: Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997;278:672-675.
83. Protin U, Schweighoffer T, Jochum W, Hilberg F: CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J Immunol 1999;163:4917-4923.
84. Tang A, Amagai M, Granger LG, Stanley JR, Udey MC: Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 1993;361: 82-85.
85. 6 integrins are required for Langerhans cell migration from the epidermis. J Exp Med 1997;186:1725-1735.
86. Osada A, Nakashima H, Furue M, Tamaki K: Up regulation of CD44 expression by tumor necrosis factor-α is neutralized by interleukin-10 in Langerhans cells. J Invest Dermatol 1995;105:124-127.
87. Weiss JM, Sleeman J, Renkl AC, et al: An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J Cell Biol 1997;137:1137-1147.
88. Weiss JM, Renkl AC, Maier CS, et al: Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J Exp Med 2001;194: 1219-1229.
89. Xu S, Ariizumi K, Caceres-Dittmar G, Edelbaum D, Bergstresser PR, Takashima A: Successive generation of antigen-presenting, dendritic cell lines from murine epidermis. J Immunol 1995;154:2697-2705.
90. Matsue H, Matsue K, Walters M, Okumura K, Yagita H, Takashima A: Induction of antigen-specific immunosuppression by CD95L cDNA-transfected "killer" dendritic cells. Nat Med 1999;5:930-937.
91. Price EA, Coombe DR, Murray JC: Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro. Int J Cancer 1996;65:513-518.
92. Föger N, Marhaba R, Zöller M: CD44 supports T cell proliferation and apoptosis by apposition of protein kinases. Eur J Immunol 2000;30:2888-2899.
93. Mummert ME, Mummert D, Edelbaum D, Hui F, Matsue H, Takashima A: Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J Immunol 2002;169: 4322-4331.
94. Do Y, Nagarkatti PS, Nagarkatti M: Role of CD44 and hyaluronic acid (HA) in activation of alloreactive and antigen-specific T cells by bone marrow-derived dendritic cells. J Immunother 2004;27:1-12.
95. Hodge-Dufour J, Noble PW, Horton MR, et al: Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol 1997;159: 2492-2500.
96. McKee CM, Penno MB, Cowman M, et al: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: the role of HA size and CD44. J Clin Invest 1996;98:2403-2413.
97. Horton MR, McKee CM, Bao C, et al: Hyaluronan fragments synergize with interferon-γ to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages. J Biol Chem 1998;273: 35,088-35,094.
98. Termeer C, Benedix F, Sleeman J, et al: Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002;195:99-111.
99. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL: Hyaluronan fragments stimulate dermal endothelial recognition of injury through TLR4. J Biol Chem 2004;279:17079-17084.
100. Teder P, Vandivier RW, Jiang D, et al: Resolution of lung inflammation by CD44. Science 2002;296: 155-158.
101. Suzuki H, Wang B, Shivji GM, et al: Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. J Invest Dermatol 2000;114: 135-141.
102. Rattis FM, Peguet-Navarro J, Staquet MJ, et al: Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells. Eur J Immunol 1996;26:449-453.
103. Nuriya S, Yagita H, Okumura K, Azuma M: The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity. Int Immunol 1996;8:917-926.
104. Mummert DI, Takashima A, Ellinger L, Mummert ME: Involvement of hyaluronan in epidermal Langerhans cell maturation and migration in vivo. J Dermatol Sci 2003;33:91-97.